Reem Kanaan

2.0k total citations
37 papers, 1.2k citations indexed

About

Reem Kanaan is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Reem Kanaan has authored 37 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 8 papers in Surgery and 7 papers in Molecular Biology. Recurrent topics in Reem Kanaan's work include Cystic Fibrosis Research Advances (21 papers), Tracheal and airway disorders (7 papers) and Neonatal Respiratory Health Research (5 papers). Reem Kanaan is often cited by papers focused on Cystic Fibrosis Research Advances (21 papers), Tracheal and airway disorders (7 papers) and Neonatal Respiratory Health Research (5 papers). Reem Kanaan collaborates with scholars based in France, United States and Jordan. Reem Kanaan's co-authors include Pierre‐Régis Burgel, D. Hubert, Daniel Dusser, Thomas A. Owen, Steven N. Popoff, Fayez F. Safadi, Isabelle Honoré, Abdulhafez Selim, Steven L. Smock and A. Paugam and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Reem Kanaan

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Reem Kanaan France 16 484 339 233 194 136 37 1.2k
Verónica Marcos Germany 15 558 1.2× 409 1.2× 158 0.7× 215 1.1× 86 0.6× 32 1.5k
Iqbal Shergill United Kingdom 14 288 0.6× 407 1.2× 101 0.4× 95 0.5× 268 2.0× 102 1.4k
Chee‐Leok Goh Singapore 25 182 0.4× 111 0.3× 140 0.6× 333 1.7× 108 0.8× 60 1.8k
Ólafur Baldursson Iceland 18 630 1.3× 361 1.1× 43 0.2× 188 1.0× 108 0.8× 28 1.2k
Serafinella Patrizia Cannavò Italy 24 169 0.3× 207 0.6× 84 0.4× 238 1.2× 150 1.1× 91 1.6k
D.G. Downey United Kingdom 20 884 1.8× 249 0.7× 116 0.5× 164 0.8× 43 0.3× 94 1.4k
Cedric Gunaratnam Ireland 20 832 1.7× 259 0.8× 286 1.2× 161 0.8× 44 0.3× 50 1.2k
Hiroshi Takahashi Japan 17 260 0.5× 171 0.5× 80 0.3× 136 0.7× 283 2.1× 66 1.0k
Susan Sencer United States 20 161 0.3× 299 0.9× 83 0.4× 80 0.4× 221 1.6× 29 1.6k
Xuan Zhou China 19 250 0.5× 364 1.1× 51 0.2× 173 0.9× 146 1.1× 91 1.4k

Countries citing papers authored by Reem Kanaan

Since Specialization
Citations

This map shows the geographic impact of Reem Kanaan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reem Kanaan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reem Kanaan more than expected).

Fields of papers citing papers by Reem Kanaan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reem Kanaan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reem Kanaan. The network helps show where Reem Kanaan may publish in the future.

Co-authorship network of co-authors of Reem Kanaan

This figure shows the co-authorship network connecting the top 25 collaborators of Reem Kanaan. A scholar is included among the top collaborators of Reem Kanaan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reem Kanaan. Reem Kanaan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parlati, Lucia, Stylianos Tzedakis, Reem Kanaan, et al.. (2025). GS-008-YI Elexacaftor-Tezacaftor-Ivacaftor Era and cystic fibrosis liver disease progression: a 10-year national study. Journal of Hepatology. 82. S6–S6.
2.
Parlati, Lucia, Stylianos Tzedakis, Samir Bouam, et al.. (2025). Cystic fibrosis liver disease progression in the era of elexacaftor–tezacaftor–ivacaftor. JHEP Reports. 7(10). 101512–101512.
3.
Chassagnon, Guillaume, Jennifer Da Silva, Isabelle Honoré, et al.. (2025). Identification of structural predictors of lung function improvement in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor using deep-learning. Diagnostic and Interventional Imaging. 107(2). 62–72.
4.
Bouazza, Naïm, Frantz Foissac, Gabrielle Lui, et al.. (2025). Population Pharmacokinetics of Elexacaftor, Tezacaftor and Ivacaftor in a Real-World Cohort of Adults with Cystic Fibrosis. Clinical Pharmacokinetics. 64(6). 959–971.
5.
Chassagnon, Guillaume, Jennifer Da Silva, Reem Kanaan, et al.. (2024). Reversal of cylindrical bronchial dilatations in a subset of adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor. European Respiratory Journal. 63(3). 2301794–2301794. 10 indexed citations
6.
Farkas, Nelli, Szabolcs Kiss, Zsolt Szakács, et al.. (2022). Efficacy of Treatments in Nonarteritic Ischemic Optic Neuropathy: A Systematic Review and Meta-Analysis. International Journal of Environmental Research and Public Health. 19(5). 2718–2718. 49 indexed citations
7.
Sohier, Pierre, Clémence Martin, C. Lheure, et al.. (2022). Acneiform Eruption Following Elexacaftor-Tezacaftor-Ivacaftor Treatment in Patients With Cystic Fibrosis. JAMA Dermatology. 159(1). 68–68. 8 indexed citations
8.
Kanaan, Reem, Nelli Farkas, Péter Hegyi, et al.. (2021). Rats sniff out pulmonary tuberculosis from sputum: a diagnostic accuracy meta-analysis. Scientific Reports. 11(1). 1877–1877. 11 indexed citations
9.
Hubert, D., R. Chiron, B. Camara, et al.. (2017). Real-life initiation of lumacaftor/ivacaftor combination in adults with cystic fibrosis homozygous for the Phe508del CFTR mutation and severe lung disease. Journal of Cystic Fibrosis. 16(3). 388–391. 72 indexed citations
10.
Gouya, H., Reem Kanaan, Isabelle Honoré, et al.. (2015). Renin-associated hypertension after bronchial artery embolization in cystic fibrosis. Journal of Cystic Fibrosis. 15(2). 213–215. 2 indexed citations
11.
Dupont, Christian, H. Gouya, D. Hubert, et al.. (2015). Complications of Peripherally Inserted Central Catheters in Adults with Cystic Fibrosis or Bronchiectasis. The Journal of Vascular Access. 16(3). 245–249. 12 indexed citations
12.
Valour, Florent, Coralie Brault, Laurence Kessler, et al.. (2012). Outcome of Cystic Fibrosis-Related Diabetes Two Years after Lung Transplantation. Respiration. 86(1). 32–38. 9 indexed citations
13.
Laborde‐Castérot, Hervé, C. Donnay, Jeanne Chapron, et al.. (2011). Employment and work disability in adults with cystic fibrosis. Journal of Cystic Fibrosis. 11(2). 137–143. 30 indexed citations
14.
Kanaan, Reem, et al.. (2011). Smoking Practices in Jordanian People and their Impact on Semen Quality and Hormonal Levels among Adult Men. Central European Journal of Public Health. 19(1). 54–59. 25 indexed citations
15.
Souilamas, Rédha, et al.. (2011). Extra corporal membrane oxygenation in general thoracic surgery: a new single veno-venous cannulation. Journal of Cardiothoracic Surgery. 6(1). 52–52. 4 indexed citations
16.
Morand, P, Pierre‐Régis Burgel, A. Carlotti, et al.. (2010). Mediastinal Tuberculosis in an Adult Patient with Cystic Fibrosis. Journal of Clinical Microbiology. 49(2). 750–751. 7 indexed citations
17.
Renno, Waleed M., Moussa Alkhalaf, Alyaa Mousa, & Reem Kanaan. (2007). A Comparative Study of Excitatory and Inhibitory Amino Acids in Three Different Brainstem Nuclei. Neurochemical Research. 33(1). 150–159. 13 indexed citations
18.
Song, Jason Jungsik, Reem Kanaan, Mario C. Rico, et al.. (2006). Connective tissue growth factor (CTGF) acts as a downstream mediator of TGF‐β1 to induce mesenchymal cell condensation. Journal of Cellular Physiology. 210(2). 398–410. 86 indexed citations
19.
Safadi, Fayez F., Jie Xu, Steven L. Smock, et al.. (2003). Expression of connective tissue growth factor in bone: Its role in osteoblast proliferation and differentiation in vitro and bone formation in vivo. Journal of Cellular Physiology. 196(1). 51–62. 172 indexed citations
20.
Selim, Abdulhafez, Samir M. Abdelmagid, Reem Kanaan, et al.. (2003). Anti-Osteoactivin Antibody Inhibits Osteoblast Differentiation and Function In Vitro. Critical Reviews in Eukaryotic Gene Expression. 13(2-4). 12–12. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Verónica Marcos Breakdown of academic impact, for papers by Iqbal Shergill Breakdown of academic impact, for papers by Chee‐Leok Goh Breakdown of academic impact, for papers by Ólafur Baldursson Breakdown of academic impact, for papers by Serafinella Patrizia Cannavò Breakdown of academic impact, for papers by D.G. Downey Breakdown of academic impact, for papers by Cedric Gunaratnam Breakdown of academic impact, for papers by Hiroshi Takahashi Breakdown of academic impact, for papers by Susan Sencer Breakdown of academic impact, for papers by Xuan Zhou
Rankless by CCL
2026